P
MEDP icon

&Partners’s Medpace MEDP Stock Holding History

&Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Buy
4,426
+66
+2% +$30.5K 0.01% 939
2026
Q1 		$2.09M Sell
4,360
-458
-10% -$235K 0.01% 879
2025
Q4 		$2.71M Buy
4,818
+392
+9% +$223K 0.01% 724
2025
Q3 		$2.28M Buy
4,426
+103
+2% +$45K 0.01% 700
2025
Q2 		$1.36M Buy
4,323
+2,399
+125% +$720K 0.01% 841
2025
Q1 		$606K Buy
1,924
+739
+62% +$249K 0.01% 1044
2024
Q4 		$405K Buy
+1,185
New +$402K ﹤0.01% 1169

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

&Partners's MEDP Position: Q2 2026 in Review

&Partners increased its Medpace (MEDP) stake by 1.5% in Q2 2026, buying an estimated $30.5K and bringing the position to 4,426 shares worth $2.34M. The position accounts for 0.01% of the portfolio, ranked #939.

&Partners first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.71M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • &Partners held 4,426 shares of Medpace worth $2.34M as of Q2 2026.
  • &Partners bought 66 Medpace shares in Q2 2026, an estimated $30.5K.
  • Medpace made up 0.01% of &Partners's portfolio in Q2 2026, its #939 holding.
  • &Partners first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • &Partners's Medpace position peaked at $2.71M in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.